CERUSO, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 5.850
EU - Europa 1.868
AS - Asia 1.368
SA - Sud America 272
Continente sconosciuto - Info sul continente non disponibili 78
AF - Africa 29
OC - Oceania 23
Totale 9.488
Nazione #
US - Stati Uniti d'America 5.787
RU - Federazione Russa 722
IT - Italia 552
SG - Singapore 365
CN - Cina 288
HK - Hong Kong 248
BR - Brasile 220
VN - Vietnam 202
IE - Irlanda 196
KR - Corea 125
SE - Svezia 89
FI - Finlandia 67
FR - Francia 61
DE - Germania 52
IN - India 47
CA - Canada 39
PL - Polonia 34
ES - Italia 32
GB - Regno Unito 24
AU - Australia 23
IQ - Iraq 21
AR - Argentina 15
EC - Ecuador 14
BD - Bangladesh 13
CI - Costa d'Avorio 10
ID - Indonesia 9
TR - Turchia 9
UA - Ucraina 9
MX - Messico 8
PK - Pakistan 8
CO - Colombia 7
JO - Giordania 7
NL - Olanda 7
JP - Giappone 6
PY - Paraguay 6
CL - Cile 5
PT - Portogallo 5
CH - Svizzera 4
DZ - Algeria 4
EG - Egitto 4
JM - Giamaica 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AL - Albania 3
KE - Kenya 3
PA - Panama 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
LT - Lituania 2
LV - Lettonia 2
MY - Malesia 2
PH - Filippine 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
IR - Iran 1
KZ - Kazakistan 1
MA - Marocco 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
SN - Senegal 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 9.411
Città #
Santa Clara 1.354
Fairfield 766
Ashburn 672
Woodbridge 349
Seattle 318
Houston 294
Cambridge 277
Singapore 259
Wilmington 212
Dublin 196
Hong Kong 196
Chandler 153
Milan 139
Princeton 122
Seoul 122
Altamura 110
San Jose 105
Lawrence 97
Ann Arbor 95
Ho Chi Minh City 76
The Dalles 63
Clifton 52
Beijing 50
Lauterbourg 50
Hanoi 46
Rome 44
Los Angeles 40
Boston 39
Council Bluffs 35
Warsaw 34
Florence 32
Barcelona 30
Medford 29
Shanghai 28
Kent 27
Moscow 26
Mumbai 24
San Diego 23
Melbourne 22
Redondo Beach 22
Buffalo 19
New York 19
São Paulo 19
Munich 18
Boardman 16
Dallas 16
Falls Church 16
Bologna 13
Hefei 12
Miano 12
Chicago 11
Abidjan 10
Brooklyn 10
Falkenstein 10
Figino 10
Gavirate 10
Guangzhou 10
Montreal 10
Frankfurt am Main 9
London 9
Naples 9
Norwalk 9
Da Nang 8
Turku 8
Guayaquil 7
Hillsboro 7
Toronto 7
Turin 7
Helsinki 6
Laurel 6
New Delhi 6
Rio de Janeiro 6
San Francisco 6
Tokyo 6
Venice 6
Amsterdam 5
Andover 5
Bari 5
Haiphong 5
Hải Dương 5
Jakarta 5
Lahore 5
Monza 5
Paris 5
Quito 5
Shenzhen 5
Belo Horizonte 4
Bern 4
Biên Hòa 4
Cairo 4
Detroit 4
Goiânia 4
Padua 4
Phoenix 4
Springfield 4
Tashkent 4
Verona 4
Acton 3
Americana 3
Asunción 3
Totale 7.099
Nome #
4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic Studies 247
Geographical characterization by MAE-HPLC and NIR methodologies and carbonic anhydrase inhibition of Saffron components 230
Discovery of β-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy 224
Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties 218
7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII 206
Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations 204
Aryl-4,5-dihydro-1H-pyrazole-1-carboxamide derivatives bearing a sulfonamide moiety show single-digit nanomolar-to-subnanomolar inhibition constants against the tumor-associated human carbonic anhydrases IX and XII 201
Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII 200
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 199
Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII 195
Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII 191
Design and validation of FRESH, a drug discovery paradigm resting on robust chemical synthesis 189
New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII 186
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 178
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives 177
Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds 173
Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties 172
Development of 3-(4-aminosulphonyl)-phenyl-2-mercapto-3H-quinazolin-4-ones as inhibitors of carbonic anhydrase isoforms involved in tumorigenesis and glaucoma 171
Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII 170
New natural product carbonic anhydrase inhibitors incorporating phenol moieties 167
Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII 167
A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms 167
Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity 166
Carbonic anhydrase inhibitors: Design, synthesis, and biological evaluation of novel sulfonyl semicarbazide derivatives 166
Arylamino bisphosphonates: Potent and selective inhibitors of the tumor-associated carbonic anhydrase XII 165
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: Identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones 164
New approaches to the synthesis of sildenafil analogues and their enzyme inhibitory activity 163
Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII 162
Quinazoline-sulfonamides with potent inhibitory activity against the α-carbonic anhydrase from Vibrio cholerae 162
Inhibition studies of new ureido-substituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I-XIV. 161
A new class of quinazoline-sulfonamides acting as efficient inhibitors against the α-carbonic anhydrase from Trypanosoma cruzi 161
Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis 161
4-Functionalized 1,3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII 160
Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII 160
Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms 159
Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors 157
Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII 156
Selective inhibition of human carbonic anhydrases by novel amide derivatives of probenecid: Synthesis, biological evaluation and molecular modelling studies 154
Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors 151
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 151
Inhibition studies of bacterial, fungal and protozoan β-class carbonic anhydrases with Schiff bases incorporating sulfonamide moieties 150
Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives 150
Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling 149
Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII 148
Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds 147
Inhibition studies of Brucella suis β-carbonic anhydrases with a series of 4-substituted pyridine-3-sulphonamides 147
New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors 145
Structure–Activity Relationships of Benzenesulfonamide-Based Inhibitors towards Carbonic Anhydrase Isoform Specificity 145
Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis. 144
Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action 139
Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies 138
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 134
Sulfonamides with potent inhibitory action and selectivity against the α-carbonic anhydrase from Vibrio cholerae 133
Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis γ-carbonic anhydrase. 132
New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: Biological evaluation and molecular modelling studies 131
5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors 126
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff’s bases incorporating iminoureido moieties 119
Totale 9.488
Categoria #
all - tutte 26.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022329 0 4 43 10 6 24 9 35 16 23 34 125
2022/2023876 153 241 47 48 40 127 118 30 44 3 18 7
2023/2024212 9 24 61 9 19 11 4 29 2 8 28 8
2024/20252.646 112 227 108 284 1.099 401 63 154 39 46 60 53
2025/20262.566 172 322 160 229 257 107 297 166 162 193 72 429
2026/2027121 89 32 0 0 0 0 0 0 0 0 0 0
Totale 9.488